Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|33|5865-5872

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5865-5872

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe/simvastatin lowers LDL-cholesterol to target levels

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ezetimibe lowers LDL-cholesterol levels

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk

By  

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-11 ,pp. : 5676-5686

Bentham Science Publishers

Access to resources Recommend Favorite

High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1480-1493

Bentham Science Publishers

Access to resources Recommend Favorite

Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts

By Michalik M.   Pierzchalska M.   Pabianczyk-Kulka A.   Korohoda W.  

European Journal of Pharmacology, Vol. 475, Iss. 1, 2003-08 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite